Percutaneous cryotherapy for renal tumours (IPG402)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous cryotherapy for renal tumours.
This document replaces previous guidance on cryotherapy for renal cancers (interventional procedure guidance 207)
Renal cancer occurs in the lining of the very small tubes in the kidney. Cryotherapy uses cold temperatures to destroy cancer cells through the insertion of a surgical instrument that applies freezing temperatures (cryoprobe) into the tumour.
M13.8 Other specified percutaneous puncture of kidney
Y13.2 Cryotherapy to lesion of organ NOC
Y53.- Approach to organ under image control
Note: Codes within category Y53.- are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.
In addition ICD-10 codes C64.X Malignant neoplasm of kidney, except renal pelvis, C65.X Malignant neoplasm of renal pelvis orC79.0 Secondary malignant neoplasm of kidney and renal pelvis are assigned for renal malignancies or D30.0 Benign neoplasm of kidney or D30.1 Benign neoplasm of renal pelvis for benign neoplasms of the kidney.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG402 Percutaneous cryotherapy for renal tumours: guidance (web format)
- Percutaneous cryotherapy for renal cancer: equality impact assessment
- Percutaneous cryotherapy for renal tumours - Overview
- Percutaneous cryotherapy for renal cancer: consultation comments
- Percutaneous cryotherapy for renal cancer - Consultation Document
This page was last updated: 10 October 2012
- Web format
- Full Guidance (PDF)
- IPG402 Trin canser yr aren drwy ddefnyddio nodwyddau wedi'u rhewi (cryotherapi) a drosglwyddir drwy'r croen: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
- None available
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.